Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Heart Diseases × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Cardiotoxicity 3 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Heart Failure 2 Glioblastoma 2 Endometrial Neoplasms 2 Endometrial Hyperplasia 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Precancerous Conditions 1 Polycystic Ovary Syndrome 1 Overall Survival 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1

Interventions

liposomal doxorubicin 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡